4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Source: SeekingAlpha
2026-01-14 13:35:58 ET
4D Molecular Therapeutics, Inc. (FDMT) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 10:30 AM EST...
Read the full article on Seeking Alpha
For further details see:
4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
4D Molecular Therapeutics Inc.
NASDAQ: FDMT
FDMT Trading
0.53% G/L:
$9.57 Last:
422,343 Volume:
$9.60 Open:
FDMT Latest News
February 09, 2026 08:00:00 am
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
FDMT Stock Data
$519,643,507
47,993,463
N/A
51
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
